Skip to main content

Table 3 Proportions of statin prescription in bivariate analysis.

From: Patterns and predictors of statin prescription in patients with type 2 diabetes

Characteristic

Primary prevention

Secondary prevention

 

Percent statin use

Percent statin use

Number

n = 27,322

18.5%

n = 17,571

38.1%

Sex

  

   Male

18.5%

41.3%

   Female

18.5%

34.4%

Age (years)

  

   <40

11.7%

37.8%

   ≥40 and <50

14.7%

43.3%

   ≥50 and <60

18.9%

43.3%

   ≥60 and <70

21.2%

43.3%

   ≥70 and <80

17.9%

36.8%

   ≥80

11.7%

21.9%

Age at diagnosis of diabetes (years)

  

   <45

16.6%

44.8%

   ≥45 and <55

19.0%

42.1%

   ≥55 and <65

20.5%

41.0%

   ≥65

16.4%

31.8%

Diabetes duration (years)

  

   <1

11.4%

37.9%

   ≥1 and <5

19.3%

39.2%

   ≥5 and <10

18.9%

38.0%

   ≥10

20.2%

37.1%

Body mass index (kg/m 2 )

  

   <25

16.5%

33.0%

   ≥25 and <30

19.3%

39.1%

   ≥30 and <35

19.1%

40.7%

   ≥35

16.9%

37.6%

Smoking status

  

   Never smoker

18.1%

35.2%

   Former smoker

20.1%

44.8%

   Current smoker

18.5%

36.0%

Hypertension

  

   no

11.7%

22.9%

   yes

19.9%

39.0%

HbA1c (%)

  

   <6.5

17.8%

36.9%

   ≥6.5 and <7.5

19.2%

39.8%

   ≥7.5 and <8.5

18.8%

36.7%

   ≥8.5

17.6%

38.5%

Albuminuria

  

   No albuminuria

17.4%

37.4%

Albuminuria

(≥20 mg/l)

19.0%

39.1%

Lipoprotein concentrations (mg/dl)

  

   Total cholesterol

  

<200

19.9%

47.2%

≥200 and <240

16.2%

34.8%

≥240

19.7%

32.6%

   LDL cholesterol

  

<100

23.8%

54.9%

≥100 and <130

19.7%

42.0%

≥130 and <160

16.9%

32.0%

≥160

19.0%

30.9%

   HDL cholesterol

  

<40 (M) or <50 (F)

19.9%

38.2%

≥40 (M) or ≥50 (F)

19.1

39.9%

   Triglycerides

  

<150

9.8%

37.3%

≥150 and <400

20.0%

38.9%

≥400

22.9%

45.4%

Estimated 5-year cardiovascular risk (%)

  

   <5

6.6%

 

   ≥5 and <10

13.9%

 

   ≥10 and <15

19.7%

 

   ≥15 and <20

23.4%

 

   ≥20 and <25

23.9%

 

   ≥25 and <30

26.9%

 

   ≥30

26.9%

 

Atherosclerotic complications

  

   Coronary heart disease

 

40.1%

   Cerebrovascular disease

 

37.3%

   Peripheral arterial occlusive disease

 

38.0%

  1. Subjects were stratified according to primary or secondary prevention and groups were analyzed separately. Confidence intervals and odds ratios for receiving a statin can be obtained from Additional file 1.